Steven J. Drews

8.6k citations

186 papers · 3.9k indexed · 1 hit paper · h-index 34

Epidemiology top 0.5%
Infectious Diseases top 0.5%
Microbiology top 0.5%
Molecular Biology
Pulmonary and Respiratory Medicine top 10%

Co-authors: Cameron Griffiths David Marchant Nathalie Bastien Danuta M. Skowronski Gaston De Serres Jonathan B. Gubbay James A. Dickinson Mel Krajden
Topics: Respiratory viral infections research (58 papers)Influenza Virus Research Studies (56 papers)SARS-CoV-2 and COVID-19 Research (34 papers)
Cited by: Microbiology Infectious Diseases Epidemiology
Journals: SHILAP Revista de lepidopterologíaAnnals of Internal Medicine PLoS ONE
Partner nations: Canada United States United Kingdom

In The Last Decade

Steven J. Drews

176 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment

2016 420 citations Cameron Griffiths, Steven J. Drews et al. profile →

Peers

Countries citing papers authored by Steven J. Drews

Since Specialization

Citations

This map shows the geographic impact of Steven J. Drews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Drews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Drews more than expected).

Fields of papers citing papers by Steven J. Drews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Drews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Drews. The network helps show where Steven J. Drews may publish in the future.

Co-authorship network of co-authors of Steven J. Drews

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Drews. A scholar is included among the top collaborators of Steven J. Drews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Drews. Steven J. Drews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nondisclosure of use of antiretroviral medications in Canadian blood donors 2025 ·Transfusion ·Mindy Goldman,Steven J. Drews,Chanson J. Brumme,Hope R. Lapointe,Timothy Tang,(unknown),Sheila F. O’Brien	0
2	Influenza and COVID‐19 vaccination in Canadian blood donors: A comparison across pre‐ and post‐pandemic periods 2025 ·Vox Sanguinis ·Sheila F. O’Brien,(unknown),Mindy Goldman,Steven J. Drews	0
3	Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: Insight into a low-risk undiagnosed population 2024 ·BMC Public Health ·Sheila F. O’Brien,Behrouz Ehsani‐Moghaddam,(unknown),Wenli Fan,Mindy Goldman,Steven J. Drews	2
4	End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral 2024 ·Vox Sanguinis ·Antoine Lewin,Mindy Goldman,Michael P. Busch,Katy Davison,Thijs van de Laar,Pierre Tiberghien,Eilat Shinar,Sheila F. O’Brien,Gilles Lambert,Stephen K. Field,Tor Hervig,Darrell H. S. Tan,Brian Custer,Steven J. Drews,Marion C. Lanteri,(unknown),Eleonora Widmer,(unknown),Christian Renaud,Marc Germain	7
5	SARS‐CoV‐2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays 2024 ·Vox Sanguinis ·Christian Renaud,Antoine Lewin,Yves Grégoire,Nathalie Simard,Émilie Vallières,(unknown),Steven J. Drews,Sheila F. O’Brien,Clara Di Germanio,Michael P. Busch,Marc Germain,Renée Bazin	2
6	Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 2023 ·Microbiology Spectrum ·Yi-Chan Lin,David H. Evans,(unknown),(unknown),Kento T. Abe,Bhavisha Rathod,Karen Colwill,Anne‐Claude Gingras,Ashleigh R. Tuite,Qilong Yi,Sheila F. O’Brien,Steven J. Drews	0
7	Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination 2023 ·Access Microbiology ·Michael Asamoah-Boaheng,Brian Grunau,(unknown),Mohammad Ehsanul Karim,Tracy L Kirkham,Pascal M. Lavoie,(unknown),Steven J. Drews,Sheila F. O’Brien,Vilte Barakauskas,Ana Márquez,Agatha N. Jassem,David A. Goldfarb	2
8	Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression 2022 ·Pharmaceutics ·Khushwant S. Bhullar,Manal A. Nael,Khaled M. Elokely,Steven J. Drews,Jianping Wu	1
9	Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses 2022 ·Microbiology Spectrum ·Yi-Chan Lin,David H. Evans,(unknown),(unknown),Queenie Hu,Reuben Samson,Kento T. Abe,Bhavisha Rathod,Karen Colwill,Anne‐Claude Gingras,Ashleigh R. Tuite,Qilong Yi,Sheila F. O’Brien,Steven J. Drews	7
10	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard 2021 ·PLoS ONE ·Sahar Saeed,Sheila F. O’Brien,Kento T. Abe,Qilong Yi,Bhavisha Rathod,Jenny Wang,Mahya Fazel‐Zarandi,Ashleigh R. Tuite,David N. Fisman,Heidi Wood,Karen Colwill,Anne‐Claude Gingras,Steven J. Drews	12
11	A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study 2021 ·Vaccine ·Rachel Savage,Christopher Bell,Christiaan H. Righolt,Krista M. Wilkinson,Kevin L. Schwartz,Cynthia Chen,Shelly Bolotin,Shelley L. Deeks,Steven J. Drews,Frances Jamieson,Caitlin Johnson,Jeffrey C. Kwong,Salaheddin M. Mahmud,Margaret L. Russell,Kimberley Simmonds,Lawrence W. Svenson,Natasha S. Crowcroft	3
12	SARS‐CoV‐2 seroprevalence among blood donors after the first COVID‐19 wave in Canada 2021 ·Transfusion ·Sahar Saeed,Steven J. Drews,Chantale Pambrun,Qilong Yi,(unknown),Sheila F. O’Brien	35
13	An international comparison of anti‐SARS‐COV‐2 assays used for seroprevalence surveys from blood component providers 2021 ·Vox Sanguinis ·Antoine Lewin,Steven J. Drews,(unknown),Christian Erikstrup,Sahar Saeed,Helen M. Faddy,(unknown),Brian Custer,Sheila F. O’Brien,(unknown)	9
14	Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review 2020 ·Transfusion ·J LEBLANC,Marc Germain,Gilles Delage,Sheila F. O’Brien,Steven J. Drews,Antoine Lewin	30
15	Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol 2019 ·BMJ Open ·Allison N. Scott,Sarah A. Buchan,Jeffrey C. Kwong,Steven J. Drews,Kimberley Simmonds,Lawrence W. Svenson	3
16	A Virological and Phylogenetic Analysis of the Emergence of New Clades of Respiratory Syncytial Virus 2017 ·Scientific Reports ·(unknown),Cameron Griffiths,(unknown),Leanne M. Bilawchuk,(unknown),(unknown),Julian W. Tang,Bart Hazes,Steven J. Drews,David Marchant	11
17	Identification of Enteric Viruses in Oral Swabs from Children with Acute Gastroenteritis 2017 ·Journal of Molecular Diagnostics ·Ran Zhuo,Brendon Parsons,Bonita E. Lee,Steven J. Drews,Linda Chui,Marie Louie,(unknown),Stephen B. Freedman,Samina Ali,Xiaoli Pang	17
18	Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance inNeisseria gonorrhoeae, Canada 2015 ·Emerging infectious diseases ·Irene Martín,(unknown),(unknown),Vanessa Allen,Brigitte Lefebvre,Linda Hoang,Steven J. Drews,Greg B. Horsman,John Wylie,David Haldane,Richard Garceau,Sam Ratnam,Tom Wong,Chris Archibald,M. R. Mulvey	33
19	Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants 2012 ·The Journal of Infectious Diseases ·Naveed Z. Janjua,Danuta M. Skowronski,Gaston De Serres,(unknown),Natasha S. Crowcroft,Marsha Taylor,Anne‐Luise Winter,Travis Salway,Kevin Fonseca,Hugues Charest,Steven J. Drews,Suzana Sabaiduc,Nathalie Bastien,Yan Li,Jennifer L. Gardy,Martin Petric	48
20	Use of the Seeplex RV Detection kit for surveillance of respiratory viral outbreaks in Toronto, Ontario, Canada. 2008 ·PubMed ·Steven J. Drews,Joanne Blair,(unknown),(unknown),Laura Burton,Tony Mazzulli,Donald E. Low	21

About Steven J. Drews

Steven J. Drews is a scholar working on Infectious Diseases, Microbiology and Epidemiology, having authored 186 papers that have together received 3.9k indexed citations. Recurring topics across this work include Respiratory viral infections research (58 papers), Influenza Virus Research Studies (56 papers) and SARS-CoV-2 and COVID-19 Research (34 papers). The work is most often cited by research in Microbiology (624 citations), Infectious Diseases (1.7k citations) and Epidemiology (2.5k citations). Steven J. Drews has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Cameron Griffiths, David Marchant, Nathalie Bastien, Danuta M. Skowronski, Gaston De Serres, Jonathan B. Gubbay, James A. Dickinson, Mel Krajden, Catharine Chambers and David N. Fisman. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact